SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
About
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
Founders
- Ira Spector
- Alla Arzumanyan
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in SFA Therapeutics.
See family office activity